Multi-Leu peptide

The Multi-Leu peptide (ML-peptide) is a potent, competitive PACE4 inhibitor with a Ki of 22 nM, mimicking the natural substrate to block catalytic activity. It is a valuable research tool for elucidating the specific role of PACE4 in prostate cancer progression, applicable in both in vitro and in vivo experimental models.